View in EDS HTML Full Text PDF Full Text

Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer: The Alliance A011502 Randomized Trial.

Saved in:
Bibliographic Details
Title: Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer: The Alliance A011502 Randomized Trial.
Authors: Chen WY; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts., Ballman KV; Department of Biostatistics, Mayo Clinic, Rochester, Minnesota., Partridge AH; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts., Hahn OM; Alliance Protocol Operations Office, University of Chicago, Chicago, Illinois., Briccetti FM; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts., Irvin WJ; Bon Secours Cancer Institute, Richmond, Virginia., Symington B; Memorial Hospital of Sweetwater County, Rock Springs, Wyoming., Visvanathan K; Sidney Kimmel Cancer Center at Johns Hopkins University, Baltimore, Maryland., Pohlmann PR; Department of Breast Medical Oncology, MD Anderson Cancer Center, University of Texas, Houston., Openshaw TH; Cape Cod Hospital, Hyannis, Massachusetts., Weiss A; Department of Surgery, University of Rochester, Rochester, New York., Winer EP; Yale Cancer Center, New Haven, Connecticut., Carey LA; UNC Lineberger Cancer Center, University of North Carolina, Chapel Hill., Holmes MD; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Source: JAMA [JAMA] 2024 May 28; Vol. 331 (20), pp. 1714-1721.
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1538-3598
DOI:10.1001/jama.2024.4840